Once again, Shoolini University proved it is at the top of e-learning and collaborative research! EduWeb 2020, an international e-seminar series, was a big draw with extensive participation of 672 registrations, including 141 from outside Shoolini, faculty and students, both.?
The e-seminar was Inaugurated by Shoolini University founder and VC Dr PK Khosla with the message to all viewers to use this opportunity to innovate and explore. During the first session, Dr Chandima, CISIR, Sri Lanka, emphasised the role of Ayurvedic principles to boost immunity and combat COVID 19. Dr Ashutosh, AIIMS, Patna, presented a clinical study of COVID 19 patients in the second session and concluded that the virus lived in the GIT, lungs, and brain too.
In the concluding session, Dr Alice, Karuna Medical College, Coimbatore, gave a clinical perspective of drug development with case studies on medicines.
Day two of the informative and educational e-seminar opened many doors for pharma graduates. Dr Amal Kumar, Drug Controller, Government of India, asked pharma graduates to take the opportunity available at the drug regulatory authority. Dr Hardik, R&D, Vasu Research Centre, Vadodra, deliberated about the application of herbal drug technology for ancient Ayurvedic products, a practical aspect. Concluding the second day of the e-seminar, IAS Sujal, Collector and Magistrate, who did B Pharm & M Pharm, asked the youth to Follow your Dreams.
On Day three, Bharat, Abbott, provided the practical aspects of a pharmaceutical production unit and validation in every batch produced. Dr Maiko, University of Pennsylvania, USA, presented her research involving modern tools of evaluation in neuropharmacology for Dementia in AD. The amazing e-seminar came to an end with Dr Harsh, Creighton University, USA, sharing the basic concepts of solubility and its modern evaluation process.
The Valedictory Session was presided over by our guest and Shoolini University founder and Director Vishal Anand, who shared his views about the evolutionary changes pre-and-post-COVID 19 times.
